BGNE

BeiGene, Ltd. (BGNE)

Last Price$226.70.0%
Market Cap$1,846.9M
LTM EPS
($7.7)
YoY Growth
-16.6%
3Y CAGR
-18.4%
5Y CAGR
-11.2%
Stock quality & Intrinsic value
5/10
1,137.7% undervalued

BeiGene, Ltd. EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
EPS
($0.1)
($0.4)
($1.8)
($3.0)
($2.0)
($12.2)
($15.8)
($19.2)
($15.2)
($19.4)
($8.5)
BGNE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BGNE and see if it's the right time to invest.
Dive in

BeiGene, Ltd. (BGNE) EPS comparison analysis

Crunching data... Almost there!

BGNE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is BeiGene, Ltd.'s EPS?

As of today, BeiGene, Ltd.'s last 12-month EPS is ($7.7), based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is BeiGene, Ltd.'s EPS growth rate?

Over the last year, BeiGene, Ltd.'s EPS growth was (16.6%). The average annual EPS growth rates for BeiGene, Ltd. have been (17.3%) over the past three years, (11.2%) over the past five years.

3) Is BeiGene, Ltd.'s EPS growth rate Good?

Over the last year, BeiGene, Ltd.'s EPS growth was (16.6%), which is lower than industry growth of (0.2%). It indicates that BeiGene, Ltd.'s EPS growth is Bad.